skip to the content

Clinical Trials

Rituximab in SLE

Rituximab in SLE: Effects of Immune Reconstitution on Treatment Response

Protocol ID

06.08.094T

Protocol Description

This study is collecting samples from patients with systemic lupus erythematosus (SLE). The purpose of this study is to look at characteristics of patients' B cells after treatment with rituximab.

Eligibility Criteria

Patients with systemic lupus erythematosus (SLE) who have previously been treated with rituximab

Primary Investigator(s)

  • Richard Furie, MD

Contact Information

Donna Ammirati
(516) 708-2556
dammirati@nshs.edu

Last Update

April 2, 2010
top
  • Share this Page
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Lupus:
top
top